| Summarized Financial Information for the Equity Method Investments |
Summarized financial information for the equity method investments as of March 31, 2025 and December 31, 2024 (balance sheet) and for the three months ended March 31, 2025 and March 31, 2024 (statement of income) is as follows (in ‘000s): Balance Sheets (in ‘000s)
|
|
|
|
|
|
|
|
|
|
|
As of
March 31,
2025 |
|
|
As of
December 31,
2024 |
|
Assets |
|
|
|
|
|
|
Investments at fair value (cost of $480,106 and $509,896, respectively) |
|
$ |
397,769 |
|
|
$ |
426,163 |
|
Cash and cash equivalents |
|
|
1,585 |
|
|
|
13,722 |
|
Other assets |
|
|
10,857 |
|
|
|
11,875 |
|
Total assets |
|
|
410,211 |
|
|
|
451,759 |
|
Liabilities |
|
|
|
|
|
|
Accrued expenses |
|
|
2,127 |
|
|
|
1,970 |
|
Other liabilities |
|
|
1,772 |
|
|
|
14,310 |
|
Total liabilities |
|
|
3,899 |
|
|
|
16,280 |
|
Total equity |
|
|
406,312 |
|
|
|
435,479 |
|
Total liabilities and equity |
|
$ |
410,211 |
|
|
$ |
451,759 |
|
Statements of Income (in '000s)
|
|
|
|
|
|
|
|
|
|
|
For the Three
Months Ended
March 31, 2025 |
|
|
For the Three
Months Ended
March 31, 2024 |
|
Total income |
|
$ |
4,192 |
|
|
$ |
13,348 |
|
Total expenses |
|
|
1,008 |
|
|
|
1,503 |
|
Net investment income |
|
|
3,184 |
|
|
|
11,845 |
|
Net realized gain/ (loss) |
|
|
(3,206 |
) |
|
|
155 |
|
Net change in unrealized appreciation/ (depreciation) |
|
|
1,999 |
|
|
|
(709 |
) |
Net income (loss) |
|
$ |
1,977 |
|
|
$ |
11,291 |
|
|
|
|
|
|
|
|
|
|
For the Six
Months Ended
March 31, 2025 |
|
|
For the Six
Months Ended
March 31, 2024 |
|
Total income |
|
$ |
10,889 |
|
|
$ |
29,109 |
|
Total expenses |
|
|
2,194 |
|
|
|
2,797 |
|
Net investment income |
|
|
8,695 |
|
|
|
26,312 |
|
Net realized gain/ (loss) |
|
|
(3,117 |
) |
|
|
(951 |
) |
Net change in unrealized appreciation/ (depreciation) |
|
|
(51,410 |
) |
|
|
(8,312 |
) |
Net income (loss) |
|
$ |
(45,832 |
) |
|
$ |
17,049 |
|
|